Strategies based on the regulation of IGF-1 and the suppression of MSTN increase muscle growth and aid recovery from cachexia, and thus, drugs and inhibitors used to treat cachexia should have anti-inflammatory and appetite-stimulating properties. Here, MSTN is linked to Cachexia.